Tumour-Induced Osteomalacia Market estimated to move ahead at a value CAGR of 2.8% by the end of 2032 – Persistence Market Research New York, Sept. 08, 2022 (GLOBE NEWSWIRE) -- The tumour-induced osteomalacia market was worth US$ 111.3 Million in 2021, by treatment, and the market is expected to expand at a CAGR of 2.8% over the...